1,862
Views
93
CrossRef citations to date
0
Altmetric
Review Article

Gut microbiota modulates drug pharmacokinetics

, &
Pages 357-368 | Received 16 Apr 2018, Accepted 03 Jul 2018, Published online: 19 Sep 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Amina Džidić-Krivić, Jasna Kusturica, Emina Karahmet Sher, Nejra Selak, Nejra Osmančević, Esma Karahmet Farhat & Farooq Sher. (2023) Effects of intestinal flora on pharmacokinetics and pharmacodynamics of drugs. Drug Metabolism Reviews 55:1-2, pages 126-139.
Read now

Articles from other publishers (92)

Valentina Andreozzi, Rocco Capuano, Sara Scannapieco, Francesca Barra, Beatrice d’Arco, Caterina Giordano, Miriam Caterino, Umberto De Marca, Federico Di Filippo, Maria Di Gregorio & Paolo Barone. (2023) Bariatric surgery and dimethyl fumarate-induced lymphopenia in patients with multiple sclerosis. Neurological Sciences 45:6, pages 2807-2810.
Crossref
Sriram Seshadri, Devanshi Gajjar, Aneri Joshi, Zeel Bhatia & Sunny Kumar. (2024) Understanding and role of gut microbiota on drug response and toxicity. Journal of Toxicological Studies 2:1, pages 1252.
Crossref
Paula Freitas & Sara Ribeiro. 2024. HIV Treatment - New Developments. HIV Treatment - New Developments.
Patrick Jimonet, Céline Druart, Stéphanie Blanquet-Diot, Lilia Boucinha, Stephanie Kourula, Françoise Le Vacon, Sylvie Maubant, Sylvie Rabot, Tom Van de Wiele, Frank Schuren, Vincent Thomas, Bernard Walther & Michael Zimmermann. (2024) Gut Microbiome Integration in Drug Discovery and Development of Small Molecules. Drug Metabolism and Disposition 52:4, pages 274-287.
Crossref
Louis B. DeRidder, Kyle A. Hare, Aaron Lopes, Josh Jenkins, Nina Fitzgerald, Emmeline MacPherson, Niora Fabian, Josh Morimoto, Jacqueline N. Chu, Ameya R. Kirtane, Wiam Madani, Keiko Ishida, Johannes L.P. Kuosmanen, Naomi Zecharias, Christopher M. Colangelo, Hen-Wei Huang, Makaya Chilekwa, Nikhil B. Lal, Shriya S. Srinivasan, Alison M. Hayward, Brian M. Wolpin, David Trumper, Troy Quast, Douglas A. Rubinson, Robert Langer & Giovanni Traverso. (2024) Closed-loop automated drug infusion regulator: A clinically translatable, closed-loop drug delivery system for personalized drug dosing. Med.
Crossref
Mohamed Kamel, Sami Aleya, Majed Alsubih & Lotfi Aleya. (2024) Microbiome Dynamics: A Paradigm Shift in Combatting Infectious Diseases. Journal of Personalized Medicine 14:2, pages 217.
Crossref
Shuaiqi Wang, Dianwen Ju & Xian Zeng. (2024) Mechanisms and Clinical Implications of Human Gut Microbiota-Drug Interactions in the Precision Medicine Era. Biomedicines 12:1, pages 194.
Crossref
Ying Zhou, Yintao Zhang, Donghai Zhao, Xinyuan Yu, Xinyi Shen, Yuan Zhou, Shanshan Wang, Yunqing Qiu, Yuzong Chen & Feng Zhu. (2024) TTD: Therapeutic Target Database describing target druggability information . Nucleic Acids Research 52:D1, pages D1465-D1477.
Crossref
Sayantap Datta, Krishna M. Boini & Saisudha Koka. 2024. Lipophilic Vitamins in Health and Disease. Lipophilic Vitamins in Health and Disease 127 146 .
Mihaela Andreescu. (2023) Molecular Insights Into the Role of Gut Microbiota in Antibiotic Therapy Selection and Resistance Mitigation. Cureus.
Crossref
Arumugam Vignesh, Thomas Cheeran Amal, Subramaniam Selvakumar & Krishnan Vasanth. (2023) Unraveling the role of medicinal plants and Gut microbiota in colon cancer: Towards microbiota- based strategies for prevention and treatment. Health Sciences Review 9, pages 100115.
Crossref
Jie Fu, Hang Yu, Qinglan Guo, Yanan Wang, Hui Xu, Jinyue Lu, Jiachun Hu & Yan Wang. (2023) Metabolic Transformation of Gentiopicrin, a Liver Protective Active Ingredient, Based on Intestinal Bacteria. Molecules 28:22, pages 7575.
Crossref
Xin Y. Chu & Paul C.L. Ho. 2023. Oral Bioavailability and Drug Delivery. Oral Bioavailability and Drug Delivery 483 500 .
Fabiana Furci, Nicola Cicero, Alessandro Allegra & Sebastiano Gangemi. (2023) Microbiota, Diet and Acute Leukaemia: Tips and Tricks on Their Possible Connections. Nutrients 15:19, pages 4253.
Crossref
Juanhong Zhang, Yuemei Sun, Jiaxin He, Guofan Wu, Rong Wang & Junmin Zhang. (2023) Comprehensive Investigation of the Influence of High-Altitude Hypoxia on Clopidogrel Metabolism and Gut Microbiota. Current Drug Metabolism 24:10, pages 723-733.
Crossref
Tayebe Shahbazi, Bita Bakhshi, Mohammad Sadegh Fazeli & Elahe Derakhshan-Nezhadc. (2023) Bacterial biomarkers: new aspects of colorectal tumors diagnosis: reality or fantasy. European Journal of Cancer Prevention 32:5, pages 485-497.
Crossref
Ying Dong, Xiao Li, Yicheng Zhao, Xueyang Ren, Yuan Zheng, Ruolan Song, Xiangjian Zhong, Dongjie Shan, Fang Lv, Qingyue Deng, Xianxian Li, Yingyu He, Keyan Chai, Xiuhuan Wang & Gaimei She. (2023) Biotransformation and metabolism of three methyl salicylate glycosides by gut microbiota in vitro. Journal of Pharmaceutical and Biomedical Analysis 233, pages 115474.
Crossref
Ruolin Li, Fereshteh Shokri, Alejandro Lopez Rincon, Fernando Rivadeneira, Carolina Medina-Gomez & Fariba Ahmadizar. (2023) Bi-Directional Interactions between Glucose-Lowering Medications and Gut Microbiome in Patients with Type 2 Diabetes Mellitus: A Systematic Review. Genes 14:8, pages 1572.
Crossref
Mohamed T. Elsebay, Noura G. Eissa, Gehan F. Balata, Mohammad Amjad Kamal & Hanan M. Elnahas. (2023) Nanosuspension: A Formulation Technology for Tackling the Poor Aqueous Solubility and Bioavailability of Poorly Soluble Drugs. Current Pharmaceutical Design 29:29, pages 2297-2312.
Crossref
Junmin Zhang, Rong Wang & Sofia Azeredo Pereira. (2023) Editorial: Drug metabolism and transport: the Frontier of personalized medicine. Frontiers in Pharmacology 14.
Crossref
Nahathai Dukaew, Patcharawadee Thongkumkoon, Nutnicha Sirikaew, Sivamoke Dissook, Wannachai Sakuludomkan, Siripong Tongjai, Parameth Thiennimitr, Mingkwan Na Takuathung, Juthipong Benjanuwattra, Prachya Kongthaweelert & Nut Koonrungsesomboon. (2023) Gut Microbiota-Mediated Pharmacokinetic Drug–Drug Interactions between Mycophenolic Acid and Trimethoprim-Sulfamethoxazole in Humans. Pharmaceutics 15:6, pages 1734.
Crossref
Juanhong Zhang, Jiaxin He, Jumin Huang, Xuefeng Li, Xiaoqing Fan, Wenbin Li, Guofan Wu, Chun Xie, Xing-Xing Fan, Junmin Zhang, Xiaojun Yao, Rong Wang & Elaine Lai-Han Leung. (2023) Pharmacokinetics, absorption and transport mechanism for ginseng polysaccharides. Biomedicine & Pharmacotherapy 162, pages 114610.
Crossref
Sourabh Chatterjee, Leander Corrie, Mahesh Hanmantrao, Sukriti Vishwas, Rajan Kumar, Faisal Alotaibi, Mohammad Javed Ansari, Zia ur Rehman, Omji Porwal, Rubiya Khursheed, Vancha Harish, Gaurav Gupta, Bimlesh Kumar, Pankaj Kumar Singh, Kuppusamy Gowthamarajan, Anindita De, Swathi Sudhakar, M.S. Umashankar, Monica Gulati, Kamal Dua & Sachin Kumar Singh. (2023) Quality by design-oriented formulation optimization and characterization of guar gum-pectin based oral colon targeted liquisolid formulation of xanthohumol. Journal of Drug Delivery Science and Technology 82, pages 104350.
Crossref
Stef Deyaert, Frédéric Moens, Walter Pirovano, Bartholomeus van den Bogert, Eline Suzanne Klaassens, Massimo Marzorati, Tom Van de Wiele, Michiel Kleerebezem & Pieter Van den Abbeele. (2023) Development of a reproducible small intestinal microbiota model and its integration into the SHIME®-system, a dynamic in vitro gut model. Frontiers in Microbiology 13.
Crossref
Rajat Sharma, Swati Singh, Nisha Tewari & Priyankar Dey. (2023) A toxic shrub turned therapeutic: The dichotomy of Nerium oleander bioactivities. Toxicon 224, pages 107047.
Crossref
Kien P. Malarney & Pamela V. Chang. (2023) Chemoproteomic Approaches for Unraveling Prokaryotic Biology. Israel Journal of Chemistry 63:3-4.
Crossref
Yorinobu Maeda & Teruo Murakami. (2023) Diagnosis by Microbial Culture, Breath Tests and Urinary Excretion Tests, and Treatments of Small Intestinal Bacterial Overgrowth. Antibiotics 12:2, pages 263.
Crossref
Mohammed H. Qusa, Khaldoun S. Abdelwahed, Ronald A. Hill & Khalid A. El Sayed. (2023) S-(−)-Oleocanthal Ex Vivo Modulatory Effects on Gut Microbiota. Nutrients 15:3, pages 618.
Crossref
Xiao shan Wang, Pei xuan Li, Bao shan Wang, Wang dong Zhang & Wen hui Wang. (2023) Integrated omics analysis reveals the immunologic characteristics of cystic Peyer’s patches in the cecum of Bactrian camels. PeerJ 11, pages e14647.
Crossref
Haigang Li, Yi Zhou, Luanfeng Liao, Hongyi Tan, Yejun Li, Zibo Li, Bilan Zhou, Meihua Bao & Binsheng He. (2023) Pharmacokinetics effects of chuanxiong rhizoma on warfarin in pseudo germ-free rats. Frontiers in Pharmacology 13.
Crossref
Francesca Pirini, Michela Cortesi, Maria Maddalena Tumedei, Michele Zanoni, Sara Ravaioli & Sara Bravaccini. (2023) Tumor resident microbiota and response to therapies: An insight on tissue bacterial microbiota. Frontiers in Cell and Developmental Biology 10.
Crossref
Rolf Teschke. (2022) Treatment of Drug-Induced Liver Injury. Biomedicines 11:1, pages 15.
Crossref
Yao Zhou, Chendan Zhou & Aijun Zhang. (2022) Gut microbiota in acute leukemia: Current evidence and future directions. Frontiers in Microbiology 13.
Crossref
Yogesh Garg, Navjot Kanwar, Shruti Chopra, Murtaza M. Tambuwala, Hemraj Dodiya, Amit Bhatia & Abhinav Kanwal. (2022) Microbiome Medicine: Microbiota in Development and Management of Cardiovascular Diseases. Endocrine, Metabolic & Immune Disorders - Drug Targets 22:14, pages 1344-1356.
Crossref
Nahid Hosseinzadeh Gharajeh, Hadi Pourjafar, Hoda Derakhshanian, Hamed Mohammadi, Abolfazl Barzegari & Solat Eslami. (2022) Gut Microbiota Might Act as a Potential Therapeutic Pathway in COVID-19. Current Pharmaceutical Biotechnology 23:15, pages 1837-1850.
Crossref
Louis DeRidder, Douglas A. Rubinson, Robert Langer & Giovanni Traverso. (2022) The past, present, and future of chemotherapy with a focus on individualization of drug dosing. Journal of Controlled Release 352, pages 840-860.
Crossref
Zhujiang Dai, Jihong Fu, Xiang Peng, Dong Tang & Jinglue Song. (2022) Intestinal Microbiota: The Driving Force behind Advances in Cancer Immunotherapy. Cancers 14:19, pages 4796.
Crossref
Lenka Jourova, Eva Anzenbacherova, Zdenek Dostal, Pavel Anzenbacher, Philippe Briolotti, Emilie Rigal, Martine Daujat-Chavanieu & Sabine Gerbal-Chaloin. (2022) Butyrate, a typical product of gut microbiome, affects function of the AhR gene, being a possible agent of crosstalk between gut microbiome, and hepatic drug metabolism. The Journal of Nutritional Biochemistry 107, pages 109042.
Crossref
Hao Cheng, Juan Liu, Yuzhu Tan, Wuwen Feng & Cheng Peng. (2022) Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine. Journal of Pharmaceutical Analysis 12:4, pages 541-555.
Crossref
Zaiquan Dong, Xiaoling Shen, Yanni Hao, Jin Li, Haizhen Xu, Li Yin & Weihong Kuang. (2022) Gut microbiome: A potential indicator for predicting treatment outcomes in major depressive disorder. Frontiers in Neuroscience 16.
Crossref
Iva Markulin, Marija Matasin, Viktorija Erdeljic Turk & Melita Salković-Petrisic. (2022) Challenges of repurposing tetracyclines for the treatment of Alzheimer’s and Parkinson’s disease. Journal of Neural Transmission 129:5-6, pages 773-804.
Crossref
Anne-Virginie Desruelle, Sébastien de Maistre, Sandrine Gaillard, Simone Richard, Catherine Tardivel, Jean-Charles Martin, Jean-Eric Blatteau, Alain Boussuges, Sarah Rives, Jean-Jacques Risso & Nicolas Vallee. (2022) Cecal Metabolomic Fingerprint of Unscathed Rats: Does It Reflect the Good Response to a Provocative Decompression?. Frontiers in Physiology 13.
Crossref
Kimberley E. Steele, Gregory P. Prokopowicz, Joseph P. Canner, Civonnia Harris, Robert A. Jurao, Thomas S. Kickler, Michael B. Streiff & Brent G. Petty. (2022) The APB study: apixaban pharmacokinetics in bariatric patients before to 1 year after vertical sleeve gastrectomy or Roux-en-Y gastric bypass. Surgery for Obesity and Related Diseases 18:5, pages 594-603.
Crossref
Leena Zino, Jurjen S. Kingma, Catia Marzolini, Olivier Richel, David M. Burger & Angela Colbers. (2022) Implications of Bariatric Surgery on the Pharmacokinetics of Antiretrovirals in People Living with HIV. Clinical Pharmacokinetics 61:5, pages 619-635.
Crossref
Vijay Nirusimhan, Daniel Andrew Gideon, Abhinav Parashar, Sangavi Jeyachandran, Jeyakanthan Jeyaraman, Gowthamkumar Subbaraj & Langeswaran Kulanthaivel. (2022) Structural Modeling of Drosophila melanogaster Gut Cytochrome P450s and Docking Comparison of Fruit Fly Gut and Human Cytochrome P450s. Current Drug Metabolism 23:4, pages 299-316.
Crossref
Yuan Bin Liu & Ming Kai Chen. (2022) The impact of proton pump inhibitors in liver diseases and the effects on the liver. Journal of Digestive Diseases 23:4, pages 196-208.
Crossref
Jeon-Kyung Kim, Min Sun Choi, Hye Hyun Yoo & Dong-Hyun Kim. (2022) The Intake of Coffee Increases the Absorption of Aspirin in Mice by Modifying Gut Microbiome. Pharmaceutics 14:4, pages 746.
Crossref
Héctor Argüello, Irene Magdalena Rodríguez‐Gómez, Jose María Sánchez‐Carvajal, Francisco José Pallares, Iván Díaz, Raúl Cabrera‐Rubio, Fiona Crispie, Paul D. Cotter, Enric Mateu, Gerard Martín‐Valls, Librado Carrasco & Jaime Gómez‐Laguna. (2021) Porcine reproductive and respiratory syndrome virus impacts on gut microbiome in a strain virulence‐dependent fashion. Microbial Biotechnology 15:3, pages 1007-1016.
Crossref
Pierre H. H. Schneeberger, Morgan Gueuning, Sophie Welsche, Eveline Hürlimann, Julian Dommann, Cécile Häberli, Jürg E. Frey, Somphou Sayasone & Jennifer Keiser. (2022) Different gut microbial communities correlate with efficacy of albendazole-ivermectin against soil-transmitted helminthiases. Nature Communications 13:1.
Crossref
Jinxiao Zhai, Xiaoru Dong, Fenglian Yan, Hongsong Guo & Jinling Yang. (2022) Oleandrin: A Systematic Review of its Natural Sources, Structural Properties, Detection Methods, Pharmacokinetics and Toxicology. Frontiers in Pharmacology 13.
Crossref
Yumei Zhou, Haihong Zhao, Tieshan Wang, Xiaoshan Zhao, Ji Wang & Qi Wang. (2022) Anti-Inflammatory and Anti-asthmatic Effects of TMDCT Decoction in Eosinophilic Asthma Through Treg/Th17 Balance. Frontiers in Pharmacology 13.
Crossref
Chiara Puricelli, Roberta Rolla, Luca Gigliotti, Elena Boggio, Eleonora Beltrami, Umberto Dianzani & Roberto Keller. (2022) The Gut-Brain-Immune Axis in Autism Spectrum Disorders: A State-of-Art Report. Frontiers in Psychiatry 12.
Crossref
Laura E. McCoubrey, Hannah Batchelor, Abdul W. Basit, Simon Gaisford & Mine Orlu. 2022. Biopharmaceutics. Biopharmaceutics 277 295 .
Xue Bai, Guiqin Liu, Jianxin Yang, Junbo Zhu & Xiangyang Li. (2022) Gut Microbiota as the Potential Mechanism to Mediate Drug Metabolism Under High-altitude Hypoxia. Current Drug Metabolism 23:1, pages 8-20.
Crossref
Tomoaki Ishida, Kohei Jobu, Kei Kawada, Shumpei Morisawa, Tetsushi Kawazoe, Hisashi Shiraishi, Hiroko Fujita, Satomi Nishimura, Hitomi Kanno, Mitsue Nishiyama, Kazuo Ogawa, Yasuyo Morita, Kazuhiro Hanazaki & Mitsuhiko Miyamura. (2022) Impact of Gut Microbiota on the Pharmacokinetics of Glycyrrhizic Acid in Yokukansan, a Kampo Medicine. Biological and Pharmaceutical Bulletin 45:1, pages 104-113.
Crossref
Huijue Jia. 2022. Investigating Human Diseases with the Microbiome. Investigating Human Diseases with the Microbiome 157 187 .
Alan Talevi. 2022. The ADME Encyclopedia. The ADME Encyclopedia 725 732 .
Yusha Luo & Tingting Zhou. (2021) Connecting the dots: Targeting the microbiome in drug toxicity. Medicinal Research Reviews 42:1, pages 83-111.
Crossref
Connor O'Farrell, Konstantinos Stamatopoulos, Mark Simmons & Hannah Batchelor. (2021) In vitro models to evaluate ingestible devices: Present status and current trends. Advanced Drug Delivery Reviews 178, pages 113924.
Crossref
Ana Rita da Silva Ferreira, Anne-Grete Märtson, Alyse de Boer, Hannah R. Wardill, Jan-Willem Alffenaar, Hermie J. M. Harmsen & Wim J. E. Tissing. (2021) Does Chemotherapy-Induced Gastrointestinal Mucositis Affect the Bioavailability and Efficacy of Anti-Infective Drugs?. Biomedicines 9:10, pages 1389.
Crossref
Susanne B. Haga. (2021) Revisiting Secondary Information Related to Pharmacogenetic Testing. Frontiers in Genetics 12.
Crossref
Wenpei Shi, Yi Hu, Zhu Ning, Fan Xia, Meiying Wu, Yue O.O. Hu, Cheng Chen, Stefanie Prast-Nielsen & Biao Xu. (2021) Alterations of gut microbiota in patients with active pulmonary tuberculosis in China: a pilot study. International Journal of Infectious Diseases 111, pages 313-321.
Crossref
Lin Pan, Xuze Ai, Tianyu Fu, Li Ren, Qingsen Shang, Guoyun Li & Guangli Yu. (2021) In vitro fermentation of hyaluronan by human gut microbiota: Changes in microbiota community and potential degradation mechanism. Carbohydrate Polymers 269, pages 118313.
Crossref
Eunwoo Kim, Andrew Hyoungjin Kim, Yujin Lee, Sang Chun Ji, Joo‐Youn Cho, Kyung‐Sang Yu & Jae‐Yong Chung. (2021) Effects of vancomycin‐induced gut microbiome alteration on the pharmacodynamics of metformin in healthy male subjects. Clinical and Translational Science 14:5, pages 1955-1966.
Crossref
Erin Milner, Benjamin Stevens, Martino An, Victoria Lam, Michael Ainsworth, Preston Dihle, Jocelyn Stearns, Andrew Dombrowski, Daniel Rego & Katharine Segars. (2021) Utilizing Probiotics for the Prevention and Treatment of Gastrointestinal Diseases. Frontiers in Microbiology 12.
Crossref
Xintong Zhang, Ying Han, Wei Huang, Mingji Jin & Zhonggao Gao. (2021) The influence of the gut microbiota on the bioavailability of oral drugs. Acta Pharmaceutica Sinica B 11:7, pages 1789-1812.
Crossref
Nutthapoom Pathomthongtaweechai & Chatchai Muanprasat. (2021) Potential Applications of Chitosan-Based Nanomaterials to Surpass the Gastrointestinal Physiological Obstacles and Enhance the Intestinal Drug Absorption. Pharmaceutics 13:6, pages 887.
Crossref
Jun Chen, Ruilan Du, Chunyan Huang, Lihong Jia, Defu Tie, Zhaohui Fan, Chuting Zhou, Qizhu Chen & Huaben Bo. (2021) Gut microbiota affects the efficacy of Danggui Buxue Tang by affecting plasma concentration of active ingredients. Journal of Ethnopharmacology 270, pages 113835.
Crossref
Sofia Cussotto, Jacinta Walsh, Anna V. Golubeva, Alexander V. Zhdanov, Conall R. Strain, Fiona Fouhy, Catherine Stanton, Timothy G. Dinan, Niall P. Hyland, Gerard Clarke, John F. Cryan & Brendan T. Griffin. (2021) The gut microbiome influences the bioavailability of olanzapine in rats. eBioMedicine 66, pages 103307.
Crossref
Yuseok Moon. (2021) Predictive and Preventive Mucosal Communications in Particulate Matter Exposure-Linked Renal Distress. Journal of Personalized Medicine 11:2, pages 118.
Crossref
Tanmay Padhye, Kavya Sree Maravajjala, Karnam Laxmi Swetha, Swati Sharma & Aniruddha Roy. (2021) A comprehensive review of the strategies to improve oral drug absorption with special emphasis on the cellular and molecular mechanisms. Journal of Drug Delivery Science and Technology 61, pages 102178.
Crossref
K. Maselis, R. Žekevičiūtė & A. Vaitkus. (2021) Refractoriness to drugs in migraine may be the result of developing anti-drug antibodies. Medical Hypotheses 146, pages 110459.
Crossref
Priyanka Shinde, Hina F. Badgujar & Umesh Kumar. 2021. Emerging Trends in Nanomedicine. Emerging Trends in Nanomedicine 25 50 .
Alan Talevi. 2021. The ADME Encyclopedia. The ADME Encyclopedia 1 8 .
O.H. Korotkyi, T.V. Luhovska, T.M. Serhiychuk, K.O. Dvorshchenko, T.M. Falalyeyeva & L.I. Ostapchenko. (2020) The Gut Microbiota of Rats under Experimental Osteoarthritis and Administration of Chondroitin Sulfate and Probiotic. Mikrobiolohichnyi Zhurnal 82:6, pages 64-73.
Crossref
Leon Fisher, Alexander Fisher & Paul N Smith. (2020) Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). Journal of Clinical Medicine 9:10, pages 3253.
Crossref
Carolina Ferreira, Sofia D. Viana & Flávio Reis. (2020) Gut Microbiota Dysbiosis–Immune Hyperresponse–Inflammation Triad in Coronavirus Disease 2019 (COVID-19): Impact of Pharmacological and Nutraceutical Approaches. Microorganisms 8:10, pages 1514.
Crossref
Juanhong Zhang, Mingxia Zhang, Junmin Zhang & Rong Wang. (2020) Enhanced P-glycoprotein expression under high-altitude hypoxia contributes to increased phenytoin levels and reduced clearance in rats. European Journal of Pharmaceutical Sciences 153, pages 105490.
Crossref
Yun-Chung Hsiao, Chih-Wei Liu, Liang Chi, Yifei Yang & Kun Lu. (2020) Effects of Gut Microbiome on Carcinogenic DNA Damage. Chemical Research in Toxicology 33:8, pages 2130-2138.
Crossref
Daniel Porat & Arik Dahan. (2020) Medication Management after Bariatric Surgery: Providing Optimal Patient Care. Journal of Clinical Medicine 9:5, pages 1511.
Crossref
Jian-Feng Huang, Qi Zhao, Man-Yun Dai, Xue-Rong Xiao, Ting Zhang, Wei-Feng Zhu & Fei Li. (2020) Gut microbiota protects from triptolide-induced hepatotoxicity: Key role of propionate and its downstream signalling events. Pharmacological Research 155, pages 104752.
Crossref
Tianjie Yuan, Jin Wang, Letian Chen, Jinjun Shan & Liuqing Di. (2020) Lactobacillus murinus Improved the Bioavailability of Orally Administered Glycyrrhizic Acid in Rats. Frontiers in Microbiology 11.
Crossref
Sarah Israel, Hila Elinav, Ram Elazary, Daniel Porat, Roni Gibori, Arik Dahan, Carmil Azran & Ehud Horwitz. (2020) Case Report of Increased Exposure to Antiretrovirals following Sleeve Gastrectomy. Antimicrobial Agents and Chemotherapy 64:4.
Crossref
Kieran Rea, Timothy G. Dinan & John F. Cryan. (2020) Gut Microbiota: A Perspective for Psychiatrists. Neuropsychobiology 79:1, pages 50-62.
Crossref
Joseph L. Dempsey & Julia Yue Cui. (2019) Microbiome Is a Functional Modifier of P450 Drug Metabolism. Current Pharmacology Reports 5:6, pages 481-490.
Crossref
Juanhong Zhang, Yuemei Sun, Rong Wang & Junmin Zhang. (2019) Gut Microbiota-Mediated Drug-Drug Interaction between Amoxicillin and Aspirin. Scientific Reports 9:1.
Crossref
Emmanuel Biver, Francis Berenbaum, Ana M. Valdes, Islene Araujo de Carvalho, Laure B. Bindels, Maria Luisa Brandi, Philip C. Calder, Vincenzo Castronovo, Etienne Cavalier, Antonio Cherubini, Cyrus Cooper, Elaine Dennison, Claudio Franceschi, Nicholas Fuggle, Andrea Laslop, Pierre Miossec, Thierry Thomas, Sansin Tuzun, Nicola Veronese, Mila Vlaskovska, Jean-Yves Reginster & René Rizzoli. (2019) Gut microbiota and osteoarthritis management: An expert consensus of the European society for clinical and economic aspects of osteoporosis, osteoarthritis and musculoskeletal diseases (ESCEO). Ageing Research Reviews 55, pages 100946.
Crossref
Carmelo Scarpignato & Ingvar Bjarnason. (2019) Drug-Induced Small Bowel Injury: a Challenging and Often Forgotten Clinical Condition. Current Gastroenterology Reports 21:11.
Crossref
Maja Ðanić, Bojan Stanimirov, Nebojša Pavlović, Saša Vukmirović, Jelena Lazić, Hani Al-Salami & Momir Mikov. (2019) Transport and Biotransformation of Gliclazide and the Effect of Deoxycholic Acid in a Probiotic Bacteria Model. Frontiers in Pharmacology 10.
Crossref
Xiaoming Wang, Xiaoyan Chang, Xiaomei Luo, Meifeng Su, Rong Xu, Jun Chen, Yi Ding & Yue Shi. (2019) An Integrated Approach to Characterize Intestinal Metabolites of Four Phenylethanoid Glycosides and Intestinal Microbe-Mediated Antioxidant Activity Evaluation In Vitro Using UHPLC-Q-Exactive High-Resolution Mass Spectrometry and a 1,1-Diphenyl-2-picrylhydrazyl-Based Assay. Frontiers in Pharmacology 10.
Crossref
Reese Hitchings & Libusha Kelly. (2019) Predicting and Understanding the Human Microbiome’s Impact on Pharmacology. Trends in Pharmacological Sciences 40:7, pages 495-505.
Crossref
Juanhong Zhang, Junmin Zhang, Rong Wang & Zhengping Jia. (2019) Effects of Gut Microbiota on Drug Metabolism and Guidance for Rational Drug Use Under Hypoxic Conditions at High Altitudes. Current Drug Metabolism 20:2, pages 155-165.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.